Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-07 · 46 (7)
DOI: 10.1002/phar.70178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 16.06.2026. Verfasst von Shannon W Finks und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Menopause, Estrogen Replacement Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben.
Abstract (Originalsprache)
Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor and genitourinary symptoms of menopause; however, its use declined sharply following the publication of the Women's Health Initiative (WHI). Misinterpretation and limitations of WHI findings have led to persistent misconceptions and underutilization of MHT. This expert opinion aims to clarify evidence‐based approaches to MHT selection, safety, and individualized management. This article was informed by a structured narrative review of the literature with the aim to contextualize evolving pharmacotherapeutic evidence and inform clinical decision‐making. PubMed/MEDLINE, Embase, and the Cochrane Library were searched for studies published from 2002 to 2025. Key opinion statements were developed through expert consensus and paired with a synthesis of contemporary evidence to form recommendations. A critical appraisal of the WHI and subsequent analyses demonstrates that age at initiation, timing since menopause, and hormone formulation utilized significantly influence outcomes. Contemporary data support the preferential use of transdermal estradiol due to its lower risk of venous thromboembolism and favor oral micronized progesterone (MP) over synthetic progestogens when endometrial protection is required. Individualization of therapy—including formulation, route, and dosing—is emphasized as central to optimizing the benefit–risk profile. Current evidence supports the safety of low‐dose vaginal estrogen for genitourinary syndrome of menopause including in cancer survivors. Further evidence highlights potential cardiovascular and cognitive benefits when MHT is initiated within 10 years of menopause. Clinicians caring for menopausal women should promote individualized, evidence‐based MHT through education, therapeutic selection, shared decision making, and ongoing monitoring. Continued research is needed to refine dosing targets, evaluate long‐term preventive outcomes, and expand evidence for modern formulations beyond WHI‐era therapies. Ultimately, MHT should be viewed not as a one‐size‐fits‐all therapy, but as a personalized, evidence‐informed strategy that supports the health and quality of life of menopausal women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy, Memphis, Tennessee, USA.
- Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Science, Buffalo, New York, USA.
- Department of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, Indianapolis, Indiana, USA.
- Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, California, USA.
ORCID-Profile: Shannon W Finks, Nicole E Cieri-Hutcherson, Veronica Vernon, Sarah E McBane
Zitieren
APA
Finks, S. W., Cieri-Hutcherson, N. E., Vernon, V., & McBane, S. E. (2026). Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(7). https://doi.org/10.1002/phar.70178
Vancouver
Finks SW, Cieri-Hutcherson NE, Vernon V, McBane SE. Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(7). doi:10.1002/phar.70178
BibTeX
@article{Finks2026,
author = {Finks, Shannon W and Cieri-Hutcherson, Nicole E and Vernon, Veronica and McBane, Sarah E},
title = {Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2026},
volume = {46},
number = {7},
doi = {10.1002/phar.70178}
}
EUVIMED